Sodium Propionate Enhances Nrf2-Mediated Protective Defense Against Oxidative Stress and Inflammation in Lipopolysaccharide-Induced Neonatal Mice
Dan Chen,Zhi-qi Gao,Ying-ying Wang,Bin-bin Wan,Gang Liu,Jun-liang Chen,Ya-xian Wu,Qin Zhou,Shan-yu Jiang,Ren-qiang Yu,Qing-feng Pang
DOI: https://doi.org/10.2147/JIR.S303105
IF: 4.5
2021-03-10
Journal of Inflammation Research
Abstract:Dan Chen, 1, * Zhi-qi Gao, 1, * Ying-ying Wang, 1 Bin-bin Wan, 1 Gang Liu, 1 Jun-liang Chen, 1 Ya-xian Wu, 1 Qin Zhou, 2 Shan-yu Jiang, 2 Ren-qiang Yu, 2 Qing-feng Pang 1 1 Department of Physiopathology, Wuxi School of Medicine, Jiangnan University, Wuxi, 214122, Jiangsu Province, People's Republic of China; 2 Department of Neonatology, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi, 214002, Jiangsu Province, People's Republic of China *These authors contributed equally to this work Correspondence: Ren-qiang Yu 48 Huaishu Lane, Liangxi District, Wuxi, Jiangsu Province, People's Republic of China Tel +86510-82709790 Fax +86-510-82725094 Email yurenqiang553@163.com Qing-feng Pang 1800 Lihu Avenue, Binhu District, Wuxi, Jiangsu Province, People's Republic of China Tel +8651052430172 Fax +86-510-85329042 Email qfpang@jiangnan.edu.cn Background: Alveolar arrest and the impaired angiogenesis caused by chronic inflammation and oxidative stress are two main factors in bronchopulmonary dysplasia (BPD). Short-chain fatty acids (SCFAs), especially propionate, possess anti-oxidant and anti-inflammatory effects. The present study was designed to examine the roles of sodium propionate (SP) on lipopolysaccharide (LPS)-challenged BPD and its potential mechanisms. Methods: WT, Nrf2 -/- mice and pulmonary microvascular endothelial cells (HPMECs) were used in this study. LPS was performed to mimic BPD model both in vivo and vitro. Lung histopathology, inflammation and oxidative stress-related mRNA expressions in lungs involved in BPD pathogenesis were investigated. In addition, cell viability and angiogenesis were also tested. Results: The increased nuclear factor erythroid 2-related factor (Nrf2) and decreased Kelch-like ECH-associated protein-1 (Keap-1) expressions were observed after SP treatment in the LPS-induced neonatal mouse model of BPD. In LPS-induced wild-type but not Nrf2 -/- neonatal mice, SP reduced pulmonary inflammation and oxidative stress and exhibited obvious pathological alterations of the alveoli. Moreover, in LPS-evoked HPMECs, SP accelerated Nrf2 nuclear translocation presented and exhibited cytoprotective and pro-angiogenesis effects. In addition, SP diminished the LPS-induced inflammatory response by blocking the activation of nuclear factor-kappa B pathway. Moreover, pretreatment with ML385, an Nrf2 specific inhibitor, offsets the beneficial effects of SP on inflammation, oxidative stress and angiogenesis in LPS-evoked HPMECs. Conclusion: SP protects against LPS-induced lung alveolar simplification and abnormal angiogenesis in neonatal mice and HPMECs in an Nrf2-dependent manner. Keywords: sodium propionate, lipopolysaccharide, Nrf2, angiogenesis, bronchopulmonary dysplasia
immunology